Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

iBio Inc. buy El_Zocko

Start price
€638.25
18.10.14 / 50%
Target price
€937.50
23.10.14
Performance (%)
-44.81%
End price
€352.25
23.10.14
Summary
This prediction ended on 23.10.14 with a price of €352.25. The BUY prediction by El_Zocko for iBio Inc. performed very badly with a performance of -44.81%. El_Zocko has 50% into this prediction

iBio is a listed biotechnology company with the ticker symbol iBio that focuses on developing novel plant-based biologics and vaccines to combat infectious diseases and other medical conditions. The company leverages its proprietary expression technology to rapidly produce high-quality proteins at a commercial scale, providing a cost-effective and scalable alternative to traditional manufacturing processes. iBio has strategic collaborations with leading pharmaceutical companies and is actively exploring partnerships to advance its product pipeline and expand its reach. The company is headquartered in Bryan, Texas, and is publicly traded on the NYSE American stock exchange.

Performance without dividends (%)
Name 1w 1m 1y 3y
iBio Inc. - - - -
iShares Core DAX® 1.776% 3.175% 14.882% 17.660%
iShares Nasdaq 100 -1.037% 1.869% 35.463% 52.324%
iShares Nikkei 225® -0.335% 3.857% 14.485% 11.459%
iShares S&P 500 0.854% 2.567% 31.105% 47.441%

Comments by El_Zocko for this prediction

In the thread iBio Inc. diskutieren
Prediction Buy
Perf. (%) -44.81%
Target price 37.500
Change
Ends at 23.10.14

Next one

Leichter zu zocken als die Ebola-Werte, die schon lange und gut gelaufen sind.

Prediction Buy
Perf. (%) -44.81%
Target price 37.500
Change
Ends at 23.10.14

(Vom Mitglied beendet)